THE BASIC PRINCIPLES OF NANOTECHNOLOGY EVENTS

among the initially lead compounds tested in vitro and in vivo in my lab has done Phase I-IIb medical trials, as the World’s first pan-Bcl-2/Bcl-xL/Mcl-1 inhibitor entered clinic trials. Another XIAP inhibitor is also in medical trials. A regular monthly lecture on subject areas connected to nanoscience and nanotechnology specified by a professi